English
Home > Products > Captopril advance intermediate

China Captopril advance intermediate Factory

No matter new shopper or old customer, We believe in very long expression and dependable relationship for Captopril advance intermediate,CAS NO 74345-73-6,74345-73-6,Captopril intermediate,(R)-3-(ACETYLTHIO)-2-METHYLPROPIONYL, We sincerely stay up for hearing from you. Give us a chance to show you our professionalism and passion. We've been sincerely welcome superior mates from numerous circles at dwelling and overseas come to cooperate!
Captopril advance intermediate, Our mission is "Provide Products and solutions with Reliable Quality and Reasonable Prices". We welcome customers from every corner of the world to contact us for future business relationships and achieving mutual success!

Related Products

Hot Products

  • Ethyl 2-Chloroacetoacetate

    Ethyl 2-Chloroacetoacetate

    Product ​Name:Ethyl 2-Chloroacetoacetate
    Synonyms:2-Chloroacetoacetic acid ethyl ester
    Molecular Weight:164.59
    CAS NO:609-15-4
    Usage:Febuxostat
    EINECS:210-180-4
  • Tylosin tartrate

    Tylosin tartrate

    Product Name:Tylosin tartrate
    Molecular Formula:C49H81NO23
    Molecular Weight;1052.16
    CAS Registry Number;74610-55-2
  • Bictegravir Sodium

    Bictegravir Sodium

    Product Name:Bictegravir Sodium
    Molecular Formula:C21H19F3N3NaO5
    Molecular Weight:473.38
    CAS Registry Number:1807988-02-8
  • Liraglutide

    Liraglutide

    Product Name:Liraglutide
    Molecular Formula:C172H265N43O51
    Molecular Weight;3751.202
    CAS Registry Number;204656-20-2
  • Prednisolone

    Prednisolone

    Product Name:Prednisolone
    Molecular Formula:C21H28O5
    Molecular Weight:360.45
    CAS Registry Number;50-24-8
  • Alendronate sodium

    Alendronate sodium

    Product Name:Alendronate sodium
    Molecular Formula:C4H13NNaO7P2
    Molecular Weight;272.09
    CAS Registry Number;129318-43-0
  • Related Blog
  • Reviews

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept